Markets / Mutual funds / Sectoral / Thematic
Baroda BNP Paribas Mutual Fund · Equity fund · Direct plan · IDCW
Equity fund in the Sectoral / Thematic category, from Baroda BNP Paribas Mutual Fund.
Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.5 | -4.0 | -2.1 | +2.1 | +0.3 | -2.0 | ||||||
| 2026 | -4.1 | +5.8 | -4.8 | +3.9 | +4.5 | +4.3 | +5.1 | +1.3 | -3.8 | +1.0 | +2.1 |
Each month's change in NAV (the current month to the latest NAV).
Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.
| Holding | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited INE044A01036 | 8.58% |
| Torrent Pharmaceuticals Limited INE685A01028 | 7.88% |
| Divi's Laboratories Limited INE361B01024 | 7.82% |
| IPCA Laboratories Limited INE571A01038 | 6.13% |
| Laurus Labs Limited INE947Q01028 | 6.09% |
| Lupin Limited INE326A01037 | 5.79% |
| Apollo Hospitals Enterprise Limited INE437A01024 | 5.28% |
| Fortis Healthcare Limited INE061F01013 | 3.98% |
| Dr. Lal Path Labs Limited INE600L01024 | 3.47% |
| Mankind Pharma Limited INE634S01028 | 3.34% |
| Glenmark Pharmaceuticals Limited INE935A01035 | 3.11% |
| Aurobindo Pharma Limited INE406A01037 | 3.09% |
| AstraZeneca Pharma India Limited INE203A01020 | 2.79% |
| Abbott India Limited INE358A01014 | 2.50% |
| Emcure Pharmaceuticals Limited INE168P01015 | 2.39% |
| Acutaas Chemicals Limited INE00FF01025 | 2.36% |
| Zydus Lifesciences Limited INE010B01027 | 2.24% |
| Max Financial Services Limited INE180A01020 | 2.21% |
| Aster DM Quality Care Limited INE914M01019 | 2.15% |
| Concord Biotech Limited INE338H01029 | 2.11% |
| Ajanta Pharma Limited INE031B01049 | 1.56% |
| Symbiotec Pharmalab Limited INE899I01028 | 1.47% |
| Nephrocare Health Services Ltd INE428V01029 | 1.42% |
| Metropolis Healthcare Limited INE112L01020 | 1.33% |
| Dr. Reddy's Laboratories Limited INE089A01031 | 1.26% |
| Manipal Health Enterprises Ltd INE459N01021 | 1.23% |
| Gland Pharma Limited INE068V01023 | 1.19% |
| Cipla Limited INE059A01026 | 1.10% |
| Narayana Hrudayalaya Limited INE410P01011 | 0.97% |
| Inventurus Knowledge Solutions Limited INE115Q01022 | 0.90% |
| GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | 0.68% |
| Life Insurance Corporation Of India INE0J1Y01017 | 0.47% |
| Procter & Gamble Health Limited INE199A01012 | 0.17% |
| Holding | % of fund |
|---|---|
| Clearing Corporation of India Ltd | 2.78% |
| Net Receivables / (Payables) | 0.16% |
From the fund house's monthly portfolio (barodabnpparibasmf.in), as on 30 Sept 2026. Percentages are of the fund's net assets. Published about ten days after each month ends.
Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 4 Jul 2025).
| Fund size (average AUM, July - September 2026) | ₹511 cr across all plans · this plan ₹0.07 cr |
| Fund house | Baroda BNP Paribas Mutual Fund |
| Category | Equity · Sectoral / Thematic |
| Plan | Direct |
| Option | IDCW |
| Scheme code (AMFI) | 153605 |
| ISIN | INF251K01VB3 |
| NAV date | 5 Nov 2026 |
| Plan | NAV | 1 year |
|---|---|---|
| Direct · Growth | ₹11.0287 | +12.76% |
| Regular · Growth | ₹10.7786 | +10.93% |
| Regular · IDCW | ₹10.7786 | +10.93% |
| Fund | 1 year | 3 years (a year) |
|---|---|---|
| Nippon India Taiwan Equity Fund | +49.17% | +45.49% |
| HDFC Defence Fund | +18.82% | +35.64% |
| HDFC Pharma and Healthcare Fund | +26.22% | +31.34% |
| SBI HEALTHCARE OPPORTUNITIES FUND | +20.99% | +25.54% |
| HDFC Transportation and Logistics Fund | +9.04% | +25.47% |
| Mirae Asset Healthcare Fund | +22.03% | +24.65% |
| UTI - Healthcare Fund | +17.27% | +24.46% |
| ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND | +10.66% | +22.89% |
All Sectoral / Thematic funds ranked › · Compare with others ›
Information only, not investment advice.
₹11.0287 as of 5 Nov 2026, from AMFI's official NAV data.
1 year: 12.76%
Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.